MORGANTI, STEFANIA

MORGANTI, STEFANIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 2024 Curigliano, GiuseppeCriscitiello, CarmenMorganti, StefaniaCorti, ChiaraMiller, Robert + Article (author) -
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials 2024 Giugliano, FedericaUliano, JacopoMorganti, StefaniaFerraro, EmanuelaTrapani, DarioZagami, PaolaBoldrini, LauraCarnevale Schianca, AmbraCriscitiello, CarmenMarra, AntonioCurigliano, Giuseppe + Article (author) -
PARP Inhibitors for Breast Cancer Treatment 2024 Morganti StefaniaMarra AntonioGiugliano FedericaBerton Giachetti Pier Paolo MariaCurigliano GiuseppeCriscitiello Carmen + Article (author) -
I diritti dei morenti in diversi setting di cura al tempo del Covid-19. Uno studio retrospettivo trasversale sulle opinioni degli operatori sanitari. 2023 Borsellino PGallucci MMorganti SPiga AClerici CASalardi S + Article (author) -
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 2023 Sartori G.Vianello A.Nobili A.Mannucci P. M.Violi F.Franchi C.Ardoino I.Barbagallo M.Serafini G.Cappellini M. D.Fabio G.Scaramellini N.Di Stefano V.Leoni S.Di Mauro A. D.Maira D.Clerici M.Di Mauro A. D.Fabrizi M.Martelengo M.Lenti M. V.Pisati M.Cattaneo F.Manzoni F.Gallo P.Corsi M.Brucato A.Squintani G. L.Cerruti L.Di Meo I.Schiavone S.Amoruso E.Fracanzani A. L.Tiraboschi S.Cespiati A.Oberti G.Sigon G.Cinque F.Peyvandi F.Agosti P.Pagliaro E.Semproni E.Monzani V.Savojardo V.Pallini G.Kassem S.Castiglioni L.Bertolotti M.Orlandi L.Battaglia R.Maio R.Ruggeri E.Damiani G.Filippini E.Ghio R.Moreo G.Morganti S.Montalto G.Rizzo A.Catalano A.Caruso R.Quadri R.Vannini G.Harari S.Napoli F.Cattaneo M.Fracasso P.Damanti S. + Article (author) -
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 2023 Morganti, StefaniaMarra, AntonioAscione, LilianaVenetis, KonstantinosSajjadi, ElhamZagami, PaolaGiugliano, FedericaBerton Giachetti, Pier Paolo MariaCorti, ChiaraDe Camilli, ElisaCurigliano, GiuseppeFusco, NicolaCriscitiello, Carmen + Article (author) -
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 2022 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaMarra, AntonioCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioMorganti, StefaniaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist 2022 Paola ZagamiStefania MorgantiGiuseppe Curigliano + Book Part (author) -
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? 2022 Morganti S.Crimini E.Zagami P.Curigliano G. + Article (author) -
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials 2022 Venetis K.Morganti S.Sajjadi E.Curci C.Criscitiello C.Fusco N. + Article (author) -
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed? 2022 Morganti, S.Bianchini, G.Curigliano, G.Criscitiello, C. + Article (author) -
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls 2022 Morganti S.Ferraro E.Ascione L.Vivanet G.Curigliano G.Fusco N.Criscitiello C. + Article (author) -
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 2022 Morganti, SMarra, AVenetis, KSajjadi, EAscione, LCorti, CZagami, PZattoni, LCurigliano, GFusco, NCriscitiello, C + Article (author) -
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 2021 Fusco N.Sajjadi E.Venetis K.Piciotti R.Morganti S.Criscitiello C. + Article (author) -
Characterization of low HER2 expressions in de-novo metastatic breast cancer 2021 Tarantino, PZagami, PGiugliano, FCrimini, ECorti, CUliano, JMorganti, SCriscitiello, CCurigliano, G + Article (author) -
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 2021 Crimini E.Corti C.Repetto M.Giugliano F.Antonarelli G.Zagami P.Morganti S.Uliano J.Curigliano G. + Article (author) -
Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2 2021 Zagami P.Gandini S.Venturini S.Morganti S.Orecchia R.Curigliano G. + Article (author) -
Margetuximab for the treatment of HER2-positive metastatic breast cancer 2021 Morganti S.Uliano J.Giugliano F.Crimini E.Curigliano G. + Article (author) -
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 2021 Repetto M.Crimini E.Giugliano F.Morganti S.Curigliano G. + Article (author) -
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis 2021 Morganti S.Zagami P.Buccimazza G.Venetis K.Mazzarella L.Viale G.Fusco N.Criscitiello C.Curigliano G. + Article (author) -